MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
You may also like
Gainers
Latest Crypto News
Pacifica: Users who were liquidated between October 1st and December 1st will receive a 20% bonus on December transactions.
「Calm Dip Buyer」 Buys the Dips on BTC, ETH, SOL, Holding a Position Worth $13.6 Million
"The Big Short" Michael Burry Reveals Short Position on Tesla
The probability of a 25 basis point interest rate cut by the Federal Reserve in December is 87.6%.
Powell did not comment on the economy and monetary policy in his Stanford University speech
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]